Invesaro

Stocks Health care SNDL

NASDAQ · Health care

SNDL Inc. (SNDL)

SNDL Inc. reported revenue of CA$1B in fiscal 2025, up 2.8% from a year earlier. It posted a net loss of CA$15.8M. Operating cash flow minus capital spending left CA$58.1M of free cash flow in fiscal 2025. At December 31, 2025 it held CA$252.2M in cash. Its latest periodic report to the SEC is the annual report (Canadian issuer) (40-F) filed on March 12, 2026.

Price
$1.40
0.00% on the day · September 25, 2026
52-week range $1.17 to $2.89
Market cap
$364.4M
Revenue (FY2025)
CA$1B
+2.8% year on year
Net margin
-1.6%

What SNDL Inc. does

SNDL Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker SNDL.

Revenue and profit by year

Revenue
FY19: CA$66.9M CA$66.9M FY19FY20: CA$73.3M CA$73.3M FY20FY21: CA$67.3M CA$67.3M FY21FY22: CA$729.7M CA$729.7M FY22FY23: CA$957.7M CA$957.7M FY23FY24: CA$975.4M CA$975.4M FY24FY25: CA$1B CA$1B FY25
Net income
FY19: -CA$13M -CA$13M FY19FY19: -CA$271.5M -CA$271.5M FY19FY20: -CA$233.2M -CA$233.2M FY20FY21: -CA$227M -CA$227M FY21FY22: -CA$335.1M -CA$335.1M FY22FY23: -CA$172.7M -CA$172.7M FY23FY24: -CA$94.8M -CA$94.8M FY24FY25: -CA$15.8M -CA$15.8M FY25

Fiscal years as reported in annual reports. Amounts in CAD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025CA$1B-CA$6.3M-CA$15.8M-CA$0.06CA$58.1M
2024CA$975.4M-CA$103.8M-CA$94.8M-CA$0.36CA$46.3M
2023CA$957.7M-CA$163.2M-CA$172.7M-CA$0.67-CA$24.5M
2022CA$729.7M-CA$347.8M-CA$335.1M-CA$1.46-CA$17.4M
2021CA$67.3M-CA$134.4M-CA$227Mn/a-CA$159.5M
2020CA$73.3M-CA$185.4M-CA$233.2M-CA$1.10-CA$60.5M

Latest SEC filings

What SNDL Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 8, 2026
  2. August 4, 2026
  3. July 28, 2026
  4. July 28, 2026
  5. July 27, 2026
  6. July 15, 2026
  7. May 28, 2026
  8. April 29, 2026
  9. April 29, 2026
  10. April 15, 2026

Recent insider filings (Forms 3, 4 and 144): 3, the latest on December 12, 2025. Insider transactions on SEC

All filings on SEC EDGAR

Questions about SNDL

What does SNDL Inc. do?

SNDL Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker SNDL.

Is SNDL Inc. profitable?

No. In fiscal 2025 it reported a net loss of CA$15.8M on revenue of CA$1B.

How much revenue does SNDL Inc. make?

In fiscal 2025 SNDL Inc. reported revenue of CA$1B. That is 2.8% more than a year earlier.

When did SNDL Inc. last report?

Its most recent periodic report is the annual report (Canadian issuer) (40-F) filed on March 12, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 8, 2026.

Similar companies

Follow SNDL

Get an email when SNDL Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SNDL: get an email when it files

Where the numbers come from

Financial figures are the values SNDL Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.